You are here

Subscribe

Donors Your Gifts at Work

All
All

We invite you to share your story to help raise awareness. If you have been or are being treated for cancer at Duke or if you are a caregiver, we'd like to know how cancer care, research or clinical trials at Duke has affected your life. Are you a donor? If so, please consider sharing you story. Tell us why you choose to team up with Duke Cancer Institute. For more information or to share your story, please contact Sara Wajda, Director of Annual Giving, DCI Development.

Reducing Radiation May Cut Breast Cancer Treatment Costs

More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers. The researchers found that the annual estimated cost...

Duke Researchers Reveal Genetic Causes of Rare, But Lethal HSTL

Led by a team from Duke, an international group of 56 researchers has found new mutations identifying potential treatments and new hope for patients with hepatosplenic T cell lymphoma (HSTL or HSCTL) — one of the deadliest cancers known. Through whole exome sequencing of 68 human tissue samples...

New Tools In The Battle Against Bile Duct Cancer

Often by the time bile duct cancer is diagnosed, it’s already metastasized. Highly aggressive, bile duct cancer usually comes with limited treatment options and a poor prognosis. Because it’s a relatively rare cancer — only about 8,000 cases are diagnosed each year — additional therapies have not...

Enlisting A Dog In The Fight Against Cancer

For years, dogs have sniffed-out land mines, rescued earthquake victims, and guided the blind. Today our BFFs are teaming up with us to confront a shared formidable foe — cancer. America’s 83 million pet dogs share our environment, have similar genomes and develop spontaneous tumors much like we do...

Neuro-Onc Faculty Spotlight: Dina Randazzo, DO

Dina Randazzo, DO, was 13 when she was told that her father had less than three months to live. This event inspired her to become a neuro-oncologist, both to help people with brain tumors and to provide compassion and honesty to patients and their loved ones. In this interview, Randazzo talks to us...

Prostate Cancer Cells Grow with Malfunction of Cholesterol Control

Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem. Now a team led by researchers at the Duke Cancer Institute have identified a cellular process that cancer cells hijack to hoard cholesterol and fuel their growth...

Tumor-Seeking Salmonella Treats Brain Tumors

Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer — a strain of salmonella that usually causes food poisoning. Clinicians sorely need new treatment approaches for glioblastoma, the most aggressive form of brain cancer...

DCI Cancer Clinicians Tackle Financial Toxicity

Financial toxicity. Google it and you’ll find it’s the new catchphrase to describe the escalating costs of cancer care. The leading killer of patients under 85, the national expenditure on cancer is in the $200 billion range and overall patient spending on cancer treatment can easily reach tens of...

Mutation Could Be Vulnerable to Drugs

Breast cancer cells that carry a certain gene mutation can be induced to die using a combination of an existing targeted therapy along with an investigational molecule tested by Duke Cancer Institute researchers. When used together in preclinical experiments, the drugs shut down two of the key...

Pages